Drug discovery technologies encompass a range of tools, methodologies and processes employed in the identification and development of new pharmaceutical compounds. This market is integral to the pharmaceutical and biotechnology industries, providing essential support for the discovery of both small molecule drugs and biologic drugs.
The drug discovery technologies market consists of revenues earned by entities (organizations, sole traders and partnerships) from sales of drug discovery technologies that include a range of scientific approaches and methodologies aimed at identifying and developing new pharmaceuticals for treating diseases.
The global drug discovery technologies market was valued at $41,445.3 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 9.0%.
Increased Pharmaceutical Research And Development (R&D) Expenditure
The increased pharmaceutical spending on research and development of new drugs drove the growth of the drug discovery technologies market during the historic period. Pharmaceutical firms invested significantly in research and development (R&D) to innovate and address medical gaps. This investment drove adoption of advanced drug discovery tech, streamlining development processes. For example, the global pharmaceutical companies collectively spent $139 billion on research and development in 2022. Also in 2019, globally pharmaceutical companies spent an average of roughly 25% of their revenue on R&D. Therefore, the increased research and development expenditure in pharmaceutical supported the growth of the drug discovery technologies market.
Introduction Of Intelligent Robotics Labs To Expand AI-Driven Drug Discovery Efforts
The introduction of intelligent robotics labs marks a significant advancement in AI (artificial intelligence)-driven drug discovery efforts. These labs are equipped with automated high-throughput screening, which allows for the rapid testing of millions of compounds against specific drug targets. For example, in January 2023, Insilico Medicine, a Hong Kong-based biotechnology company that provides drug discovery technologies, launched its 6th generation Intelligent Robotics Lab in Suzhou, China, to expedite its AI-driven drug discovery process. The lab employs advanced robotics and automation to streamline drug discovery stages, spanning from target identification to lead optimization. It features automated, high-throughput screening for rapid compound testing against drug targets and robotic systems for compound synthesis and purification, facilitating the creation of novel drug candidates.
The global drug discovery technologies market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 26.61% of the total market in 2022.
Drug Discovery Technologies Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global drug discovery technologies market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for drug discovery technologies? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drug discovery technologies market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider drug discovery technologies market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by drug type, by disease application and by end-user.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the drug discovery technologies market.
- Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by technology, by drug type, by disease application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for drug discovery technologies providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Technology: High Throughput Screening; Genomics; Bioinformatics; Combinational Chemistry; Biochips; Bioanalytical Instruments; Other Technologies
- 2) By Drug Type: Small Molecule Drugs; Biologic Drugs
- 3) By End-User: Pharmaceutical Companies; Biopharmaceutical Companies; Biotechnology Companies; Research Institutes; Other End-Users
- 4) By Disease Application: Cancer Diseases; Immunological Diseases; Neurological Diseases; Cardiovascular Diseases; Other Disease Applications
- Companies Mentioned: AstraZeneca plc.; Merck KGaA; GlaxoSmithKline Plc; Pfizer Inc.; Thermo Fisher Scientific
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; drug discovery technologies indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.